The Best Way to Exercise on GLP-1 Medications: A Science-Backed Plan
GLP-1 medications help you lose weight fast. The right exercise plan decides how much of that weight is fat, and how much muscle you get to keep.
GLP-1 medications like semaglutide (Wegovy®, Ozempic®) and tirzepatide (Zepbound®, Mounjaro®) can produce dramatic weight loss results. But here’s something many patients don’t realize until it’s too late: not all of that weight is fat. Without a deliberate plan, a meaningful portion can come from muscle.
The good news? You have significant control over that outcome. The right exercise protocol, combined with adequate protein intake, can protect lean tissue and direct your body to burn fat preferentially. Below is a clear explanation of what the research shows, followed by a simple plan you can start this week.
Why Muscle Loss Is a Real Risk—and Why It Matters
During any significant caloric deficit, whether from diet, surgery, or medication, the body loses both fat and lean mass. Some lean mass loss is expected and unavoidable. The problem arises when that proportion shifts too far toward muscle.
Excess muscle loss slows your resting metabolic rate, reduces functional strength, increases fall risk (especially relevant as we age), and impairs glucose regulation. Studies estimate that without a focused plan, 20% to 40% of weight lost on GLP-1 therapy can come from lean tissue rather than fat.[4]
The intervention that changes this outcome most reliably is resistance training, paired with adequate protein. That’s not an opinion; it’s what the clinical data shows.
What the Research Actually Shows
A 2025 prospective study enrolled 200 adults who had recently started semaglutide or tirzepatide. Participants received structured coaching on resistance training and protein targets. At six months, the group had lost an average of 13% of body weight while losing only ~3% of lean mass—meaning the overwhelming majority of what they lost was fat.[3]
Broader research on GLP-1 agonists and exercise, including a 2025 review in Frontiers in Clinical Diabetes and Healthcare, confirms that resistance training is the primary lever for preserving skeletal muscle during GLP-1-driven weight loss.[5]
The Two Types of Exercise You Need
An effective exercise plan during GLP-1 therapy has two components: resistance training to protect muscle, and cardio to support cardiovascular health, energy, and metabolic efficiency. Both matter, and both are achievable without a gym membership.
1. Resistance Training — The Priority
If you can only do one type of exercise, make it resistance training. It is the single most evidence-supported intervention for lean mass preservation during caloric deficit.[5]
- Frequency: 2–3 sessions per week, with at least 48 hours between sessions targeting the same muscle groups.
- Exercises: Prioritize compound, multi-joint movements: squats, lunges, hip hinges (deadlifts or Romanian deadlifts), push-ups or chest presses, rows, and overhead presses.
- Volume: 2–3 sets of 8–12 repetitions per exercise. The final 2–3 reps of each set should feel challenging but achievable with good form.
- Equipment: Dumbbells, resistance bands, cable machines, or bodyweight all qualify. You do not need a barbell or a gym.
- Progression: Gradually increase weight, reps, or sets every 1–2 weeks to keep providing a stimulus for muscle maintenance.
2. Cardiovascular Exercise — For Heart Health and Energy
Cardio supports heart health, mood, sleep, and metabolic rate. Current guidelines recommend:[7]
- Moderate intensity: 150 minutes per week (e.g., brisk walking, cycling, swimming). A useful test: you can hold a conversation but not sing comfortably.
- Vigorous intensity: 75 minutes per week (e.g., jogging, fast cycling, aerobics). At this level, speaking in full sentences becomes difficult.
- Joint-friendly options: For patients with knee, hip, or ankle issues, water aerobics, an elliptical, or a recumbent bike are excellent low-impact alternatives.
A Sample Weekly Schedule
| Day | Activity |
|---|---|
| Monday | Resistance training — full body, 30–40 min |
| Tuesday | Brisk walk or light cardio, 30 min |
| Wednesday | Rest or gentle stretching / mobility work |
| Thursday | Resistance training — full body, 30–40 min |
| Friday | Walk, swim, or cycle — moderate pace, 30 min |
| Saturday | Resistance training or active activity (hiking, sport) |
| Sunday | Rest |
Protein: The Non-Negotiable Partner to Exercise
Exercise only preserves muscle if the body has enough dietary protein to repair and rebuild tissue after training. This is especially important on a GLP-1, because appetite suppression can significantly reduce overall food intake—and with it, protein intake.[7]
- Target: At least 1.2 g of protein per kilogram of body weight per day. To find your weight in kilograms, divide your body weight in pounds by 2.2.
- Distribution: Spread protein across all meals rather than concentrating it in one. Muscle protein synthesis responds better to consistent distribution throughout the day.
- When appetite is suppressed: Prioritize protein first at every meal. If eating feels difficult, a protein shake or high-protein snack (Greek yogurt, cottage cheese, hard-boiled eggs) can help you hit your target.
- Quality sources: Chicken, turkey, fish, eggs, Greek yogurt, cottage cheese, legumes, tofu, edamame, lean beef, and whey or plant-based protein powder.
Exercise Safety on GLP-1 Medications
GLP-1 medications are generally safe to exercise with, but a few medication-specific considerations will help you feel better and train more consistently.
- Hydration: GLP-1 medications can suppress thirst signals alongside appetite. Drink water proactively before, during, and after exercise—don’t wait until you feel thirsty.[7]
- Nausea management: If nausea is present (most common during dose escalation), schedule workouts for the time of day you feel best. Light-to-moderate movement, such as walking, can actually reduce GI discomfort.
- Pre-workout fuel: If you feel weak or dizzy during exercise, a small protein-containing snack 30–60 minutes before your session can help stabilize energy, even if appetite is low.
- Fatigue: Some patients experience increased fatigue early in treatment due to reduced caloric intake. Shorten session duration or lower intensity as needed; consistency over time matters more than any single session.
- Blood sugar awareness: Patients on concurrent insulin or sulfonylurea therapy should monitor blood glucose around exercise, as physical activity combined with these medications can lower blood sugar significantly. Discuss with your physician.
How to Start—This Week
You don’t need a gym, a trainer, or new equipment to begin. The evidence supports starting with what you have and building from there:
- Week 1: Walk 20–30 minutes most days. That’s it. Build the habit first.
- Week 2: Add two resistance sessions. Bodyweight squats, push-ups against a wall, and resistance band rows are enough to begin.
- Weeks 3–4: Add one set per exercise and, if you have dumbbells, begin adding light weight.
- Ongoing: Every 1–2 weeks, increase slightly—one more rep, a bit more weight, one more set. Small, consistent progression over months produces lasting results.
Track your sessions briefly, even just a note in your phone. Seeing your progression is one of the most powerful motivators to continue.
The Bottom Line
GLP-1 medications are a genuine advance in weight loss medicine. But the medication does not determine whether your weight loss is healthy weight loss. Your exercise and nutrition habits do. Resistance training 2–3 times per week, adequate daily protein, and consistent cardiovascular activity work together to ensure that what you lose is predominantly fat—and that the results you earn are ones you can sustain.
You don’t have to do this perfectly. You just have to start, and keep showing up.
Want a Plan Built Around Your Body?
At Body Logic Health, our physician-led team integrates GLP-1 therapy with personalized nutrition and exercise coaching. Book a $75 initial consultation at our East Orlando or DeLand clinic, or by telehealth.
Schedule My Consultation →References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. doi:10.1056/NEJMoa2032183
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216. doi:10.1056/NEJMoa2206038
- Resistance Training and Protein Intake May Lower GLP-1 RA Muscle Loss. Medscape Medical News, 2025. medscape.com
- American Diabetes Association. New GLP-1 Therapies Enhance Quality of Weight Loss by Improving Muscle Preservation, 2025. diabetes.org
- GLP-1 Agonists and Exercise: The Future of Lifestyle Prioritization. Front Clin Diabetes Healthc. 2025. doi:10.3389/fcdhc.2025.1720794
- Mass General Brigham. Preserving Lean Body Mass in Patients Taking GLP-1 for Weight Loss. Advances in Motion, 2025. advances.massgeneral.org
- Optimizing GLP-1 Therapies for Obesity and Diabetes Management. PMC / NLM, 2025. ncbi.nlm.nih.gov · Physical Activity Guidelines for Americans, 2nd ed., U.S. DHHS, 2018.